CGEM Shares Outstanding History
Below is a table of the CGEM shares outstanding history going back to 1/8/2021:

Date CGEM Shares Outstanding

Also see: CGEM Market Cap History
CGEM Historical Shares Outstanding:
+11.04% CAGR
CGEM Historical Shares Outstanding: +11.04% CAGR

Mouse over chart for data details
1/8/2021 ...11/4/2022
Cullinan Oncology is a biopharmaceutical company. Co. is evaluating its primary candidate, CLN-081, in a trial in patients with non-small cell lung cancer harboring epidermal growth factor receptor exon 20 insertion mutations who have previously received platinum-based chemotherapy. Co.'s two other clinical stage programs include CLN-049, a bispecific T cell-engaging antibody targeting FLT3 and CD3 that is in an ongoing clinical trial for patients with relapsed or refractory acute myeloid leukemia; and CLN-619, a monoclonal antibody that stabilizes a tumor cell surface target, MICA/MICB, to promote an antitumor response via activation of both natural killer cells and certain T cells. We show 9 historical shares outstanding datapoints in our coverage of CGEM's shares outstanding history.

Understanding the changing numbers of CGEM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CGEM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CGEM by allowing them to research CGEM shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree CGEM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Cullinan Management (CGEM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

CGEN Shares Outstanding History
CGIX Shares Outstanding History
CGNT Shares Outstanding History
CGTX Shares Outstanding History
CHE Shares Outstanding History
CHFS Shares Outstanding History
CHMA Shares Outstanding History
CHRS Shares Outstanding History
CI Shares Outstanding History
CINC Shares Outstanding History
More Healthcare companies »


CGEM Shares Outstanding History | | Copyright © 2017 - 2023, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.